Updates in Primary Eyecare – New developments in medical retinal disease and glaucoma.

Updates in Primary Eyecare - Modern Treatment Options in Medical Retina Disease

Date: 6/03/2024 (AEST)

Venue: Calile Hotel, 48 James St, Fortitude Valley, QLD, 4006

Provider: LVF Ophthalmology Research Centre

Contact: Michelle Carley-Lep, [E] admin@lvfeyecentre.org.au, [P] 07 3398 9494

Activity Outline

Progress in medical retinal disease diagnosis and treatments in the last two decades have astounded clinicians, with several previously untreatable conditions routinely now being associated with good long-term outcomes when treated in subspecialty practices. Recent advances are less well known and many can be applied cheaply and effectively into optometric practice. Examples include affordable full colour widefield imaging devices, FDA approved web based AI diagnostic tests for diabetic retinopathy with better accuracy than most experts, automated tools for macular degeneration prognosis and others showing efficacy for general retinal disease diagnosis and referral triaging. The need to reduce the treatment burden on patients with exudative and inflammatory disease continues to be a priority, and longer lasting anti-VEGF agents, sustained release implants and treatment approaches like gene therapy are either in use in the clinic or are being assessed by regulatory agencies. The availability of effective dry macular degeneration treatment will change the medical retina landscape forever this year and the latest information on these new agents will be presented. Finally, an update of new systemic therapies for the diseases which cause most medical retina disease will be covered. 

Learning Objectives

• Gain insight into incorporating AI into optometric practice.
• Become aware of imminent expansion of treatment options for medical retinal disease.
• Update your knowledge on new systemic therapies for the diseases which cause retinal complications.

Max CPD hours awarded: 2.5

Session Information